V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002040 | 240009437 | 1.68 | 14 | null | null | 2022-01-16 | ATG + Busulfan + Fludarabine | 02 | null | ANAGRELIDE | 100607609 |
| 240002062 | 240009443 | 0 | 33.4 | Curative (C) | 2021-08-13 | 2021-10-02 | null | N | N | CARBOPLATIN + VINCRISTINE | 101172936 |
| 240002063 | 240009444 | 1.85 | 60 | Palliative (P) | 2018-08-04 | 2018-08-04 | Imatinib 400mg | 02 | N | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100752132 |
| 240002073 | 240009445 | 1.82 | 62 | Curative (C) | null | 2020-03-29 | AML MyeChild 01 IT Cyt | 01 | N | AML 18 PILOT TRIAL | 101499218 |
| 240002074 | 240009446 | 1.7 | 102.25 | null | 2020-09-21 | 2020-10-05 | Cyclophosphamide High Dose | 02 | null | CYTARABINE HIGH DOSE | 100410732 |
| 240002076 | 240009447 | 1.5 | 81.4 | Palliative (P) | null | 2017-05-22 | CYCLO + ETOPOSIDE + NELARABINE | null | N | BUSULFAN | 100182690 |
| 240002088 | 240009449 | null | null | Curative (C) | 2020-03-15 | 2020-03-24 | Rituximab + Venetoclax | 01 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100041156 |
| 240002093 | 240009450 | 1.78 | 86.7 | Curative (C) | 2017-01-30 | 2017-01-31 | ALL UKALL2011 Maintenance A1 | 01 | N | CYTARABINE + IDARUBICIN | 100488667 |
| 240002094 | 240009451 | 1.68 | null | null | null | 2016-07-31 | IBRUTINIB | null | null | NOT MATCHED | 100807119 |
| 240002096 | 240009452 | 1.69 | 82.3 | 03 | null | 2020-08-11 | null | null | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + METHOTREXATE + RITUXIMAB + VINCRISTINE | 101337720 |
| 240002100 | 240009453 | 1.6 | 64.4 | null | null | 2016-06-13 | null | 02 | null | CISPLATIN + GEMCITABINE | 100747234 |
| 240002106 | 240009454 | 1.67 | 63 | null | null | 2021-12-16 | null | null | null | RUXOLITINIB | 100141805 |
| 240002110 | 240009456 | null | null | Disease modification (D) | 2017-01-09 | 2017-01-09 | Cytarabine High Dose | 02 | N | PEG INTERFERON | 100107521 |
| 240002121 | 240009457 | 1.72 | 81 | 03 | 2016-04-01 | 2016-04-02 | null | null | N | CHLORAMBUCIL + RITUXIMAB | 100972469 |
| 240002132 | 240009458 | 1.77 | 76 | null | 2022-03-05 | 2022-03-26 | CML Imatinib | N | null | ALL UKALL2011 AUG BFM CONS C | 101136001 |
| 240002134 | 240009459 | 1.73 | 114 | Palliative (P) | null | 2021-08-30 | GEMTUZUMAB OZOGAMICIN | null | N | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100183450 |
| 240002136 | 240009460 | 1.64 | 62.2 | Curative (C) | 2021-03-05 | 2021-04-23 | BUSULFAN | 02 | null | CNS LGG2004 03 VINC + CARBO | 101441200 |
| 240002144 | 240009461 | 0 | 101 | null | 2019-11-12 | 2019-11-16 | null | 02 | null | ALL UKALL2011 MAINTENANCE | 100133154 |
| 240002147 | 240009462 | 1.86 | 87.1 | null | 2019-06-18 | 2019-07-01 | MERCAPTOPURINE + METHOTREXATE | 02 | null | BUSULFAN | 100822982 |
| 240002152 | 240009463 | 0.81 | 75.35 | Palliative (P) | null | 2019-11-20 | R CODOX M | null | N | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 100343792 |
| 240002153 | 240009464 | 1.62 | null | null | null | 2019-04-01 | null | null | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 100732469 |
| 240002159 | 240009466 | null | 61.8 | 03 | null | 2016-10-17 | ATG + Busulfan + Fludarabine | N | N | IBRUTINIB | 101722751 |
| 240002160 | 240009467 | 0 | 88.9 | Disease modification (D) | 2016-05-04 | 2016-06-08 | null | 01 | null | IBRUTINIB + RITUXIMAB | 100300505 |
| 240002169 | 240009469 | 1.91 | 64.2 | null | 2020-12-03 | 2021-01-19 | null | N | null | FLUDARABINE + MELPHALAN | 100945623 |
| 240002170 | 240009470 | 1.1 | 92 | Curative (C) | null | 2022-01-07 | null | null | null | AML DOWNS IT CYTARABINE | 100938995 |
| 240002180 | 240009473 | null | null | Curative (C) | 2021-06-01 | 2021-07-01 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | NOT MATCHED | 100463085 |
| 240002186 | 240009475 | 1.88 | 71.6 | null | 2021-05-22 | 2021-05-27 | GEMTUZUMAB OZOGAMICIN | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101485933 |
| 240002189 | 240009477 | 1.71 | 80.4 | null | 2020-04-15 | 2020-04-15 | GDP | 02 | null | DA | 100197632 |
| 240002194 | 240009478 | 1.5 | 83.35 | null | null | 2021-01-03 | RUXOLITINIB | null | N | PEMBROLIZUMAB | 100164261 |
| 240002199 | 240009479 | 0 | 91.6 | Adjuvant (A) | 2021-12-07 | 2021-12-17 | Midostaurin | 02 | null | TRIAL | 101817798 |
| 240002206 | 240009481 | null | 82.5 | Curative (C) | 2020-12-15 | 2020-12-20 | FLAG + Idarubicin | 02 | null | CLOFARABINE + CYTARABINE | 101859904 |
| 240002222 | 240009483 | 1.82 | 59.4 | Palliative (P) | null | 2021-12-20 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | null | N | CLADRIBINE | 101586362 |
| 240002224 | 240009484 | 1.65 | 75.35 | Adjuvant (A) | null | 2021-02-26 | IPILIMUMAB + NIVOLUMAB | 01 | N | RUXOLITINIB | 100606828 |
| 240002228 | 240009485 | 1.66 | 51.4 | null | 2019-10-23 | 2019-11-14 | ANAGRELIDE | 02 | null | AML MYECHILD 01 HD ARAC | 101252329 |
| 240002234 | 240009487 | 1.63 | 76.8 | Curative (C) | 2019-11-28 | 2019-12-07 | null | 2 | null | CLADRIBINE | 101496504 |
| 240002241 | 240009488 | 1.56 | 71.9 | Not known (9) | 2019-07-13 | 2019-07-13 | BEAM | 02 | null | ALL UKALL2011 MAINTENANCE | 100540022 |
| 240002248 | 240009489 | 1.64 | 93 | null | null | 2016-06-08 | Busulfan Oral | 01 | null | RUXOLITINIB | 100581147 |
| 240002254 | 240009491 | 0 | 87.3 | null | 2021-03-01 | 2021-03-01 | ALL UKALL2011 Del Int C Recon PAsp | N | null | AML16 TRIAL | 100373241 |
| 240002273 | 240009495 | 1.56 | 16.2 | null | null | 2017-06-27 | null | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 101781462 |
| 240002277 | 240009496 | 1.62 | 63.4 | null | null | 2019-04-06 | Cyclophosphamide High Dose | null | null | IBRUTINIB | 100495092 |
| 240002279 | 240009497 | 1.71 | 70.65 | null | 2013-02-14 | 2013-02-19 | R IVAC | 02 | null | IMATINIB | 101552226 |
| 240002282 | 240009498 | 1.66 | 57.7 | null | 2019-09-18 | 2019-09-23 | CODOX M | 02 | null | IVE-R | 101256721 |
| 240002292 | 240009501 | 1.65 | 52.5 | null | 2019-07-30 | 2019-08-08 | ALL UKALL2011 Maintenance A2 | 02 | null | AML MYECHILD 01 IT CYT | 100628748 |
| 240002298 | 240009503 | 1.73 | 73.3 | null | 2020-11-23 | 2021-10-02 | R Chlorambucil | null | N | VINBLASTINE | 100054492 |
| 240002310 | 240009505 | null | 99 | Curative (C) | 2020-06-11 | 2020-07-05 | AML Interim Guidelines FLAG-Ida | N | null | ALCL ALCL 99 CLOSED AM 1, 2 OR 3 | 100045573 |
| 240002319 | 240009508 | 1.75 | 56 | null | 2021-11-07 | 2021-11-08 | Cyclophosphamide High Dose | 02 | null | VENETOCLAX | 101744469 |
| 240002326 | 240009509 | 1.78 | 82.3 | 03 | null | 2022-04-25 | CNS LGG 2004 03 vinc weekly+ carbo | null | N | ALL UKALL2011 AUG BFM CONS C | 101104111 |
| 240002341 | 240009511 | 1.76 | 79.4 | null | null | 2019-03-22 | Gilteritinib | null | null | CARBOPLATIN + VINCRISTINE | 100552467 |
| 240002351 | 240009516 | 1.77 | 84.8 | Curative (C) | 2018-03-04 | 2018-03-07 | DA-EPOCH-R | 02 | null | VENETOCLAX | 100578083 |
| 240002352 | 240009517 | 1.66 | 76.9 | Curative (C) | null | 2019-03-14 | R CODOX M | 2 | null | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 101831215 |